Tier 3 · Filer Universe

X4 Pharmaceuticals, Inc

XFOR · Nasdaq · Healthcare. Identity, market observation, SEC facts, and source links remain separate and inspectable.

Price
$3.78
+0.00%
Coverage
Tier 3
Tier 3 · Filer Universe
SEC CIK
0001501697
Liquidity rank
#3373
Observed dollar volume

Tier 3 is a directory treatment. It does not imply options, analyst estimates, or complete company-facts coverage. Missing fields stay missing.

SEC XBRL facts

FieldValuePeriod endFiling
Annual revenue$35.11M2025-12-310001501697-26-000018
Annual diluted EPS-1.872025-12-310001501697-26-000018
Quarterly revenue$2.71M2026-03-310001501697-26-000040
Quarterly diluted EPS-0.162026-03-310001501697-26-000040

SEC EDGAR Frames batch generated 2026-07-16T23:27:27.094Z. Frames are calendar-aligned and may not cover every filer or fiscal period.

Filings and machine access

Latest SEC filingsSEC company browse
SEC submissions JSONDirect upstream record
Per-symbol JSONSame-origin machine contract

Context paths

HealthcareNasdaqBMY · Tier 1 peerDHR · Tier 1 peerTMO · Tier 1 peerPFE · Tier 1 peer

Provenance